DK0944643T3 - Oxyiminopregnancarbolactoner. - Google Patents

Oxyiminopregnancarbolactoner.

Info

Publication number: DK0944643T3
Authority: DK; Denmark
Prior art keywords: oxyiminopregnancarbolactones; oxyiminopregnane; carbolactones; formula; production
Prior art date: 1996-12-01

Application number

DK97951267T

Other languages

Danish (da)

English (en)

Inventor

Henry Laurent

Ralph Lipp

Peter Esperling

Johannes-Wilhelm Tack

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-01

Filing date

1997-12-01

Publication date

2003-05-05

1997-12-01 Application filed by Schering Ag filed Critical Schering Ag

2003-05-05 Application granted granted Critical

2003-05-05 Publication of DK0944643T3 publication Critical patent/DK0944643T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Steroid Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK97951267T 1996-12-01 1997-12-01 Oxyiminopregnancarbolactoner. DK0944643T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19651000A DE19651000A1 (de)	1996-12-01	1996-12-01	Oxyiminopregnancarbolactone
PCT/EP1997/006657 WO1998024801A1 (fr)	1996-12-01	1997-12-01	Oxyiminopregnancarbolactone

Publications (1)

Publication Number	Publication Date
DK0944643T3 true DK0944643T3 (da)	2003-05-05

Family

ID=7814054

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97951267T DK0944643T3 (da)	1996-12-01	1997-12-01	Oxyiminopregnancarbolactoner.

Country Status (10)

Country	Link
US (1)	US6177416B1 (fr)
EP (1)	EP0944643B1 (fr)
AT (1)	ATE233274T1 (fr)
AU (1)	AU5485698A (fr)
CA (1)	CA2273354C (fr)
DE (2)	DE19651000A1 (fr)
DK (1)	DK0944643T3 (fr)
ES (1)	ES2191208T3 (fr)
WO (1)	WO1998024801A1 (fr)
ZA (1)	ZA9710796B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS50262B2 (sr)	1999-08-31	2018-10-31	Bayer Pharma AG	Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
EP2305267A3 (fr)	1999-08-31	2011-08-17	Bayer Schering Pharma Aktiengesellschaft	Combinaison pharmaceutique de l'éthinylestradiol et de la drospirénone pour utilisation comme contraceptif
US6787531B1 (en) *	1999-08-31	2004-09-07	Schering Ag	Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) *	2001-01-11	2002-09-19	Schering Aktiengesellschaft	Drospirenone for hormone replacement therapy
WO2003006027A1 (fr)	2001-07-13	2003-01-23	Schering Aktiengesellschaft	Combinaison de drospirenone et d'un sulfamate d'oestrogene destinee a une hormonotherapie substitutive
HRP20041121A2 (en) *	2002-04-26	2005-02-28	Schering Aktiengesellschaft	Treatment of hypertension in women receiving hormone replacement therapy
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
US20050222106A1 (en) *	2004-04-01	2005-10-06	Stefan Bracht	Drospirenone-containing preparations for transdermal use
DE102004016779A1 (de) *	2004-04-01	2006-01-19	Schering Ag	Drospirenonhaltige Zubereitungen zur transdermalen Anwendung
DE102004063864A1 (de) *	2004-12-30	2006-07-13	Schering Ag	18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
US8445469B2 (en) *	2004-12-30	2013-05-21	Bayer Intellectual Property Gmbh	18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
DE102006030416A1 (de) *	2006-06-29	2008-01-03	Bayer Schering Pharma Ag	18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007027637A1 (de)	2007-06-12	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de)	2007-06-12	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de)	2007-06-12	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
TW200927141A (en) *	2007-11-22	2009-07-01	Bayer Schering Pharma Oy	Vaginal delivery system
DE102007063496A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063499A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063501A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de)	2007-12-29	2009-09-17	Bayer Schering Pharma Aktiengesellschaft	19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063503A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2010066349A1 (fr) *	2008-12-12	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	UTILISATION DE DÉRIVÉS DE 17β-CYANO-19-ANDROST-4-ÈNE POUR PRODUIRE UN MÉDICAMENT À LIBÉRATION PROLONGÉE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE, ET MÉDICAMENT À LIBÉRATION PROLONGÉE CONTENANT DES DÉRIVÉS DE 17β-CYANO-19-ANDROST-4-ÈNE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE
WO2010066354A1 (fr) *	2008-12-12	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	UTILISATION DE DÉRIVÉS DE 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ÈNE POUR PRODUIRE UN MÉDICAMENT À LIBÉRATION PROLONGÉE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE, ET MÉDICAMENT À LIBÉRATION PROLONGÉE CONTENANT DES DÉRIVÉS DE 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ÈNE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE
WO2010066355A1 (fr) *	2008-12-12	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	UTILISATION DE DÉRIVÉS DE 17β- CYANO-19-NOR-ANDROST-4-ÈNE POUR PRODUIRE UN MÉDICAMENT À LIBÉRATION PROLONGÉE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE, ET MÉDICAMENT À LIBÉRATION PROLONGÉE CONTENANT DES DÉRIVÉS DE 17β- CYANO-19-NOR-ANDROST-4-ÈNE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE
CA2752805A1 (fr)	2009-02-18	2010-08-26	Bayer Pharma Aktiengesellschaft	Fo0rmulation comprenant de la drospirenone pour administration souscutanee ou intramusculaire
EP2398467A1 (fr)	2009-02-18	2011-12-28	Bayer Pharma Aktiengesellschaft	Particules comprenant de la drospirénone encapsulée dans un polymère
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
ES2533584T3 (es) *	2010-04-15	2015-04-13	Bayer Intellectual Property Gmbh	Formas de dosificación oral sólidas de dosis baja para TSH
DK3630724T3 (da)	2017-05-22	2021-07-26	Janssen Pharmaceuticals Inc	Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (de) *	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) *	1980-06-11	1982-01-07	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3916112A1 (de) *	1989-05-16	1990-11-22	Schering Ag	Dihydrospirorenon als antiandrogen
IL115659A (en) *	1994-10-27	2000-06-01	Akzo Nobel Nv	Steroids with a 17-spiromethylene lactone or lactol group process for their preparation and pharmaceutical compositions containing them

1996
- 1996-12-01 DE DE19651000A patent/DE19651000A1/de not_active Ceased
1997
- 1997-12-01 ES ES97951267T patent/ES2191208T3/es not_active Expired - Lifetime
- 1997-12-01 AU AU54856/98A patent/AU5485698A/en not_active Abandoned
- 1997-12-01 EP EP97951267A patent/EP0944643B1/fr not_active Expired - Lifetime
- 1997-12-01 WO PCT/EP1997/006657 patent/WO1998024801A1/fr not_active Ceased
- 1997-12-01 DE DE59709414T patent/DE59709414D1/de not_active Expired - Lifetime
- 1997-12-01 AT AT97951267T patent/ATE233274T1/de not_active IP Right Cessation
- 1997-12-01 CA CA002273354A patent/CA2273354C/fr not_active Expired - Fee Related
- 1997-12-01 DK DK97951267T patent/DK0944643T3/da active
- 1997-12-01 ZA ZA9710796A patent/ZA9710796B/xx unknown
- 1997-12-01 US US09/308,992 patent/US6177416B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE59709414D1 (de)	2003-04-03
ES2191208T3 (es)	2003-09-01
CA2273354C (fr)	2009-06-09
US6177416B1 (en)	2001-01-23
AU5485698A (en)	1998-06-29
ATE233274T1 (de)	2003-03-15
DE19651000A1 (de)	1998-06-04
EP0944643B1 (fr)	2003-02-26
WO1998024801A1 (fr)	1998-06-11
ZA9710796B (en)	1998-06-12
CA2273354A1 (fr)	1998-06-11
EP0944643A1 (fr)	1999-09-29

Publication	Publication Date	Title
DE59709414D1 (de)	2003-04-03	Oxyiminopregnancarbolactone
PT1413582E (pt)	2006-07-31	Pirrolobenzodiazepinas dimericas
MX9700885A (es)	1998-04-30	Nuevas heteroariloxazolidinonas.
SE9504661D0 (sv)	1995-12-22	New compounds
WO1996032003A3 (fr)	1997-01-03	Tetrahydro-imidazopyrido-indolediones et leur utilisation en tant que medicaments
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
IT1285770B1 (it)	1998-06-18	Composti corticoidei
EA199900598A1 (ru)	2000-02-28	Производные 1-арил- и пиридилпиразола с пестицидными свойствами
ATE126215T1 (de)	1995-08-15	Anti-entzündende 4-aminophenol-derivate.
NO990667D0 (no)	1999-02-12	Depeptid-benzamidin som kinogenase-inhibitor
HUT76511A (en)	1997-09-29	Benzoyl derivatives, preparation and use thereot
BG103219A (bg)	1999-10-29	Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
BG102623A (bg)	1999-03-31	Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства
SE9801494D0 (sv)	1998-04-28	Novel use
ES2178765T3 (es)	2003-01-01	Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
SE9903290D0 (sv)	1999-09-15	Novel compounds
DK1204659T3 (da)	2004-04-05	Serotonerge benzofuraner
SE9504662D0 (sv)	1995-12-22	New compounds
TR199701298T1 (xx)	1998-02-21	Tetralinler.
YU49316B (sh)	2005-06-10	Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije
ATE213236T1 (de)	2002-02-15	Substituierte benzyloxyimino-verbindungen
PT1104419E (pt)	2002-09-30	Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
BR9808210A (pt)	2000-05-16	Befeniloxazolinas dissubstituìdas
ES2192034T3 (es)	2003-09-16	Feniluracilos substituidos con efecto herbicida.
FI934468A0 (fi)	1993-10-11	Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter